Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 31993D0152

93/152/EEC: Commission Decision of 8 February 1993 laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

OJ L 59, 12.3.1993, p. 35–35 (ES, DA, DE, EL, EN, FR, IT, NL, PT)

⏵This document has been published in a special edition(s) (FI, SV, CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

Legal status of the document In force: This act has been changed. Current consolidated version: 01/12/2010

ELI: http://data.europa.eu/eli/dec/1993/152/oj

31993D0152

93/152/EEC: Commission Decision of 8 February 1993 laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

Official Journal L 059 , 12/03/1993 P. 0035 - 0035
Finnish special edition: Chapter 3 Volume 48 P. 0167
Swedish special edition: Chapter 3 Volume 48 P. 0167


COMMISSION DECISION of 8 February 1993 laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

(93/152/EEC)THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Directive 90/539/EEC of 15 October 1990 on animal health conditions governing intra-Community trade in and imports from third countries of poultry and hatching eggs (1), as last amended by Council Directive 92/65/EEC (2), and in particular Annex III thereof,

Whereas Annex III of Directive 90/539/EEC states that the Commission may determine the criteria for using vaccines against Newcastle disease in the context of routine vaccination programmes;

Whereas the said criteria shall ensure that live attenuated and inactivated vaccines used in routine vaccination programmes fulfil certain requirements relating in the intracerebral pathogenicity index (ICPI) in respect of the Newcastle disease virus strain used in the said vaccines;

Whereas it seems desirable that the level of intracerebral pathogenicity index virus strains to be used in vaccine production should be clearly defined;

Whereas the Scientific Veterinary Committee and the Standing Veterinary Committee have been consulted,

HAS ADOPTED THIS DECISION:

Article 1

For the use in routine vaccination programmes:

(a) live attenuated Newcastle disease vaccines shall be prepared from a Newcastle disease virus strain for which the master seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of:

(i) less than 0,4 if not less than 107 EID50 are administrated to each bird in the ICPI test;

or

(ii) less than 0,5 if not less than 108 EID50 are administered to each bird, in the ICPI test;

(b) inactivated Newcastle disease vaccines shall be prepared from a Newcastle disease virus strain for which the Master Seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of less than 0,7 if not less than 108 EID50 are administered to each bird in the ICPI test.

Article 2

The present Decision shall apply from 1 January 1995.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 8 February 1993.

For the Commission

René STEICHEN

Member of the Commission

(1) OJ No L 303, 31. 10. 1990, p. 6.

(2) OJ No L 268, 14. 9. 1992, p. 54.

Top